﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2012</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Serum uric acid and diabetic nephropathy</ArticleTitle>
    <FirstPage>37</FirstPage>
    <LastPage>38</LastPage>
    <ELocationID EIdType="doi">10.12861/jrip.2012.13</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Momeni</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.12861/jrip.2012.13</ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Implication for health policy/practice/research/medical education:Diabetic nephropathy is the most common cause of end-stage renal disease worldwide. Recently, some prospective randomized controlled trials suggested that lowering of uric acid with allopurinol could decrease the severity of proteinuria and probably slow the progression of renal failure in diabetic patients. Mechanism of beneficial effect of xanthine oxidase inhibitor may related to preventing uric acid-induced renal inflammation.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Diabetic nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Uric acid</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">End-stage renal disease</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>